BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3044581)

  • 41. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.
    Jamieson S; Alexiadis M; Fuller PJ
    Gynecol Oncol; 2004 Dec; 95(3):603-9. PubMed ID: 15581971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
    Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
    Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer.
    Jiang W; Kahn SM; Guillem JG; Lu SH; Weinstein IB
    Oncogene; 1989 Jul; 4(7):923-8. PubMed ID: 2666911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of hst-1 gene amplification in primary esophageal carcinomas and its relationship to other prognostic factors.
    Shiga C; Shiga K; Hirayama K; Katayama M; Nishihira T; Mori S
    Anticancer Res; 1994; 14(2B):651-6. PubMed ID: 8010723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ras oncogene activation in human ovarian carcinoma.
    van 't Veer LJ; Hermens R; van den Berg-Bakker LA; Cheng NC; Fleuren GJ; Bos JL; Cleton FJ; Schrier PI
    Oncogene; 1988 Feb; 2(2):157-65. PubMed ID: 3285294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of ras gene mutations and methylation state in human leukemias.
    Browett PJ; Norton JD
    Oncogene; 1989 Aug; 4(8):1029-36. PubMed ID: 2668844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequency of active ras oncogenes in human bladder cancers associated with schistosomiasis.
    Fujita J; Nakayama H; Onoue H; Rhim JS; el-Bolkainy MN; el-Aaser AA; Kitamura Y
    Jpn J Cancer Res; 1987 Sep; 78(9):915-20. PubMed ID: 3117747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction.
    Stratton MR; Fisher C; Gusterson BA; Cooper CS
    Cancer Res; 1989 Nov; 49(22):6324-7. PubMed ID: 2680062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of amplified oncogenes by differential polymerase chain reaction.
    Frye RA; Benz CC; Liu E
    Oncogene; 1989 Sep; 4(9):1153-7. PubMed ID: 2780051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In contrast to EGFr gene overexpression, H-ras gene expression decreases in human gliomas.
    Blumenstock M; Prosenc N; Patt S; Pfanne K; Drum F; Cervos-Navarro J
    Anticancer Res; 1991; 11(3):1353-7. PubMed ID: 1888172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients.
    Ranzani GN; Pellegata NS; Previderè C; Saragoni A; Vio A; Maltoni M; Amadori D
    Cancer Res; 1990 Dec; 50(24):7811-4. PubMed ID: 2253224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas.
    Tsuda T; Tahara E; Kajiyama G; Sakamoto H; Terada M; Sugimura T
    Cancer Res; 1989 Oct; 49(20):5505-8. PubMed ID: 2529025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amplified genes in cancer in upper digestive tract.
    Yoshida T; Sakamoto H; Terada M
    Semin Cancer Biol; 1993 Feb; 4(1):33-40. PubMed ID: 8095412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Function of oncogenes in neuroepithelial tumors].
    Diedrich U
    Fortschr Neurol Psychiatr; 1992 Apr; 60(4):146-53. PubMed ID: 1601384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene amplification in gastric and esophageal adenocarcinomas.
    Houldsworth J; Cordon-Cardo C; Ladanyi M; Kelsen DP; Chaganti RS
    Cancer Res; 1990 Oct; 50(19):6417-22. PubMed ID: 2400999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Co-amplification of transcriptionally active epidermal growth factor receptor and ribosomal genes in the human hepatoma cell line Li7A.
    Saint-Ruf C; Viegas-PĂ©quignot E; Alfani E; Clementi M; Dutrillaux B; Carloni G
    Oncogene; 1992 Aug; 7(8):1557-65. PubMed ID: 1321403
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Joint amplification of c-myc and c-Ha-ras oncogenes in human breast and thyroid cancer cells].
    Pluzhnikova GF; Serova OM; Kniazev PG; Fedorov SN; Novikov LB
    Eksp Onkol; 1987; 9(2):15-7. PubMed ID: 3034547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.